• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

软骨修复,第1部分:基础科学、历史回顾、患者评估及治疗选择

Cartilage restoration, part 1: basic science, historical perspective, patient evaluation, and treatment options.

作者信息

Alford J Winslow, Cole Brian J

机构信息

Shoulder and Sports Medicine Division, West Bay Orthopedics, Warwick, Rhode Island, USA.

出版信息

Am J Sports Med. 2005 Feb;33(2):295-306. doi: 10.1177/0363546504273510.

DOI:10.1177/0363546504273510
PMID:15701618
Abstract

Surgical procedures designed to treat focal chondral lesions are evolving and are supported by basic science principles of cartilage physiology and known responses to injury. Selecting the proper treatment algorithm for a particular patient depends on careful patient evaluation, including the recognition of comorbidities such as ligamentous instability, deficient menisci, or malalignment of the mechanical limb axis or extensor mechanism. These comorbidities may need to be treated in conjunction with symptomatic chondral injuries to provide a mutually beneficial effect. A central tenet of cartilage restoration is to leave future treatment options available should they become necessary. In this article (part 1), the authors review the basic science of chondral injuries, the historical perspective of the available surgical options, and present guidelines for patient evaluation and treatment.

摘要

旨在治疗局灶性软骨损伤的外科手术正在不断发展,并得到软骨生理学基础科学原理以及已知损伤反应的支持。为特定患者选择合适的治疗方案取决于对患者的仔细评估,包括识别合并症,如韧带不稳定、半月板缺损或机械性肢体轴线或伸肌机制排列不齐。这些合并症可能需要与有症状的软骨损伤一并治疗,以产生互利的效果。软骨修复的一个核心原则是在必要时保留未来的治疗选择。在本文(第1部分)中,作者回顾了软骨损伤的基础科学、现有手术选择的历史背景,并提出了患者评估和治疗指南。

相似文献

1
Cartilage restoration, part 1: basic science, historical perspective, patient evaluation, and treatment options.软骨修复,第1部分:基础科学、历史回顾、患者评估及治疗选择
Am J Sports Med. 2005 Feb;33(2):295-306. doi: 10.1177/0363546504273510.
2
Cartilage restoration, part 2: techniques, outcomes, and future directions.软骨修复,第二部分:技术、结果及未来方向。
Am J Sports Med. 2005 Mar;33(3):443-60. doi: 10.1177/0363546505274578.
3
Treatment of articular cartilage defects of the knee with autologous chondrocyte implantation.自体软骨细胞移植治疗膝关节软骨缺损
J Orthop Sports Phys Ther. 1998 Oct;28(4):241-51. doi: 10.2519/jospt.1998.28.4.241.
4
Basic science and treatment options for articular cartilage injuries.关节软骨损伤的基础科学与治疗选择
J Orthop Sports Phys Ther. 2006 Oct;36(10):717-27. doi: 10.2519/jospt.2006.2175.
5
Surgical management of articular cartilage defects of the knee.膝关节关节软骨缺损的手术治疗
Instr Course Lect. 2011;60:461-83.
6
[The future of treatment for chondral and osteochondral lesions].[软骨及骨软骨损伤的治疗前景]
Acta Orthop Traumatol Turc. 2007;41 Suppl 2:153-9.
7
Articular cartilage restoration of the knee.膝关节的关节软骨修复
Bull NYU Hosp Jt Dis. 2007;65(1):51-60.
8
Surgical restoration/repair of articular cartilage injuries in athletes.运动员关节软骨损伤的手术修复/重建。
Phys Sportsmed. 2013 May;41(2):75-86. doi: 10.3810/psm.2013.05.2017.
9
[Therapy of articular cartilage lesions].[关节软骨损伤的治疗]
Chirurg. 2008 Oct;79(10):989-98; quiuz 999-1000. doi: 10.1007/s00104-008-1600-0.
10
Basic science and surgical treatment options for articular cartilage injuries of the knee.膝关节软骨损伤的基础科学与手术治疗选择。
J Orthop Sports Phys Ther. 2012 Mar;42(3):243-53. doi: 10.2519/jospt.2012.3673. Epub 2012 Feb 29.

引用本文的文献

1
The Effects of Irisin and Bevacizumab on Hyaline Cartilage Regeneration in Osteochondral Defects: An Experimental Study in Rats.鸢尾素和贝伐单抗对骨软骨缺损中透明软骨再生的影响:一项大鼠实验研究
Clin Orthop Surg. 2025 Aug;17(4):710-720. doi: 10.4055/cios24502. Epub 2025 Jul 15.
2
The optimal adjunctive therapies for microfracture treatment of osteochondral lesions of the talus: a systematic review and network meta-analysis of randomized controlled trials.距骨骨软骨损伤微骨折治疗的最佳辅助治疗方法:一项随机对照试验的系统评价和网状Meta分析
BMC Musculoskelet Disord. 2025 Apr 16;26(1):375. doi: 10.1186/s12891-025-08636-6.
3
Incorporation of Cross-Linked Gelatin Microparticles To Enhance Cell Attachment and Chondrogenesis in Carboxylated Agarose Bioinks for Cartilage Engineering.
掺入交联明胶微粒以增强用于软骨工程的羧化琼脂糖水凝胶生物墨水中的细胞附着和软骨形成。
ACS Appl Mater Interfaces. 2025 Apr 16;17(15):22293-22307. doi: 10.1021/acsami.5c00077. Epub 2025 Apr 7.
4
Antihypertensive drug-associated adverse events in osteoarthritis: a study of a large real-world sample based on the FAERS database.骨关节炎中抗高血压药物相关不良事件:基于FAERS数据库的大型真实世界样本研究
Front Pharmacol. 2024 Sep 2;15:1404427. doi: 10.3389/fphar.2024.1404427. eCollection 2024.
5
Cartilage Integrity: A Review of Mechanical and Frictional Properties and Repair Approaches in Osteoarthritis.软骨完整性:骨关节炎中力学与摩擦特性及修复方法综述
Healthcare (Basel). 2024 Aug 19;12(16):1648. doi: 10.3390/healthcare12161648.
6
Single-plug osteochondral autograft transplantation for knee osteochondritis dissecans: Clinical improvement and long-term survivorship at a minimum ten year follow-up.单栓骨软骨自体移植治疗膝关节剥脱性骨软骨炎:至少十年随访的临床改善和长期存活率。
Int Orthop. 2024 Oct;48(10):2625-2632. doi: 10.1007/s00264-024-06267-5. Epub 2024 Aug 8.
7
Chondrotoxicity of Intra-Articular Injection Treatment: A Scoping Review.关节内注射治疗的软骨毒性:范围综述。
Int J Mol Sci. 2024 Jun 26;25(13):7010. doi: 10.3390/ijms25137010.
8
Fabrication of a Novel 3D Extrusion Bioink Containing Processed Human Articular Cartilage Matrix for Cartilage Tissue Engineering.用于软骨组织工程的新型3D挤出生物墨水的制备,该生物墨水包含经过处理的人关节软骨基质
Bioengineering (Basel). 2024 Mar 28;11(4):329. doi: 10.3390/bioengineering11040329.
9
Network-based cytokine inference implicates Oncostatin M as a driver of an inflammation phenotype in knee osteoarthritis.基于网络的细胞因子推断表明,骨桥蛋白 M 是膝骨关节炎炎症表型的驱动因素。
Aging Cell. 2024 Feb;23(2):e14043. doi: 10.1111/acel.14043. Epub 2023 Dec 18.
10
Microfracture- and Xeno-Matrix-Induced Chondrogenesis for Treatment of Focal Traumatic Cartilage Defects of the Knee: Age-Based Mid-Term Results.微骨折和异种基质诱导软骨形成治疗膝关节局灶性创伤性软骨缺损:基于年龄的中期结果
Healthcare (Basel). 2023 Nov 20;11(22):2995. doi: 10.3390/healthcare11222995.